Immunofluorescent staining assay showed that HCC cells with Drp1 overexpression exhibited a significantly increased co-localization of mtDNA and TLR9 than control cells, and DNase I treatment remarkably reversed the effect of Drp1 overexpression (Fig. 4d). The gene discussed is DNM1L; the disease is hepatocellular carcinoma.